Literature DB >> 27553415

Sputum is a surrogate for bronchoalveolar lavage for monitoring Mycobacterium tuberculosis transcriptional profiles in TB patients.

Benjamin J Garcia1, Andre G Loxton2, Gregory M Dolganov3, Tran T Van3, J Lucian Davis4, Bouke C de Jong5, Martin I Voskuil6, Sonia M Leach7, Gary K Schoolnik3, Gerhard Walzl2, Michael Strong7, Nicholas D Walter8.   

Abstract

Pathogen-targeted transcriptional profiling in human sputum may elucidate the physiologic state of Mycobacterium tuberculosis (M. tuberculosis) during infection and treatment. However, whether M. tuberculosis transcription in sputum recapitulates transcription in the lung is uncertain. We therefore compared M. tuberculosis transcription in human sputum and bronchoalveolar lavage (BAL) samples from 11 HIV-negative South African patients with pulmonary tuberculosis. We additionally compared these clinical samples with in vitro log phase aerobic growth and hypoxic non-replicating persistence (NRP-2). Of 2179 M. tuberculosis transcripts assayed in sputum and BAL via multiplex RT-PCR, 194 (8.9%) had a p-value <0.05, but none were significant after correction for multiple testing. Categorical enrichment analysis indicated that expression of the hypoxia-responsive DosR regulon was higher in BAL than in sputum. M. tuberculosis transcription in BAL and sputum was distinct from both aerobic growth and NRP-2, with a range of 396-1020 transcripts significantly differentially expressed after multiple testing correction. Collectively, our results indicate that M. tuberculosis transcription in sputum approximates M. tuberculosis transcription in the lung. Minor differences between M. tuberculosis transcription in BAL and sputum suggested lower oxygen concentrations or higher nitric oxide concentrations in BAL. M. tuberculosis-targeted transcriptional profiling of sputa may be a powerful tool for understanding M. tuberculosis pathogenesis and monitoring treatment responses in vivo. Published by Elsevier Ltd.

Entities:  

Keywords:  *Gene expression profiling; Bronchoalveolar lavage/microbiology; Computational biology/methods; Mycobacterium tuberculosis/genetics; Mycobacterium tuberculosis/physiology; Sputum/microbiology; Tuberculosis, pulmonary/epidemiology/*microbiology

Mesh:

Substances:

Year:  2016        PMID: 27553415      PMCID: PMC4999252          DOI: 10.1016/j.tube.2016.07.004

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  18 in total

Review 1.  A problem of persistence: still more questions than answers?

Authors:  Nathalie Q Balaban; Kenn Gerdes; Kim Lewis; John D McKinney
Journal:  Nat Rev Microbiol       Date:  2013-08       Impact factor: 60.633

2.  An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence.

Authors:  L G Wayne; L G Hayes
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

Review 3.  The chemotherapy of tuberculosis: past, present and future.

Authors:  D Mitchison; G Davies
Journal:  Int J Tuberc Lung Dis       Date:  2012-06       Impact factor: 2.373

4.  Unique transcriptome signature of Mycobacterium tuberculosis in pulmonary tuberculosis.

Authors:  Helmy Rachman; Michael Strong; Timo Ulrichs; Leander Grode; Johannes Schuchhardt; Hans Mollenkopf; George A Kosmiadi; David Eisenberg; Stefan H E Kaufmann
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

5.  PET/CT imaging reveals a therapeutic response to oxazolidinones in macaques and humans with tuberculosis.

Authors:  M Teresa Coleman; Ray Y Chen; Myungsun Lee; Philana Ling Lin; Lori E Dodd; Pauline Maiello; Laura E Via; Youngran Kim; Gwendolyn Marriner; Veronique Dartois; Charles Scanga; Christopher Janssen; Jing Wang; Edwin Klein; Sang Nae Cho; Clifton E Barry; JoAnne L Flynn
Journal:  Sci Transl Med       Date:  2014-12-03       Impact factor: 17.956

6.  Identifying biological themes within lists of genes with EASE.

Authors:  Douglas A Hosack; Glynn Dennis; Brad T Sherman; H Clifford Lane; Richard A Lempicki
Journal:  Genome Biol       Date:  2003-09-11       Impact factor: 13.583

7.  Mycobacterium tuberculosis gene expression during adaptation to stationary phase and low-oxygen dormancy.

Authors:  M I Voskuil; K C Visconti; G K Schoolnik
Journal:  Tuberculosis (Edinb)       Date:  2004       Impact factor: 3.131

8.  BLANNOTATOR: enhanced homology-based function prediction of bacterial proteins.

Authors:  Matti Kankainen; Teija Ojala; Liisa Holm
Journal:  BMC Bioinformatics       Date:  2012-02-15       Impact factor: 3.169

9.  Cytological and transcript analyses reveal fat and lazy persister-like bacilli in tuberculous sputum.

Authors:  Natalie J Garton; Simon J Waddell; Anna L Sherratt; Su-Min Lee; Rebecca J Smith; Claire Senner; Jason Hinds; Kumar Rajakumar; Richard A Adegbola; Gurdyal S Besra; Philip D Butcher; Michael R Barer
Journal:  PLoS Med       Date:  2008-04-01       Impact factor: 11.069

10.  Transcriptional Adaptation of Mycobacterium tuberculosis within Macrophages: Insights into the Phagosomal Environment.

Authors:  Dirk Schnappinger; Sabine Ehrt; Martin I Voskuil; Yang Liu; Joseph A Mangan; Irene M Monahan; Gregory Dolganov; Brad Efron; Philip D Butcher; Carl Nathan; Gary K Schoolnik
Journal:  J Exp Med       Date:  2003-09-01       Impact factor: 14.307

View more
  8 in total

1.  Multiplex Real-Time PCR-shortTUB Assay for Detection of the Mycobacterium tuberculosis Complex in Smear-Negative Clinical Samples with Low Mycobacterial Loads.

Authors:  Fernando Alcaide; Rocío Trastoy; Raquel Moure; Mónica González-Bardanca; Antón Ambroa; María López; Inés Bleriot; Lucia Blasco; Laura Fernandez-García; Marta Tato; German Bou; María Tomás
Journal:  J Clin Microbiol       Date:  2019-07-26       Impact factor: 5.948

Review 2.  Heterogeneous Host-Pathogen Encounters Coordinate Antibiotic Resilience in Mycobacterium tuberculosis.

Authors:  Richa Mishra; Vikas Yadav; Madhura Guha; Amit Singh
Journal:  Trends Microbiol       Date:  2020-12-10       Impact factor: 17.079

3.  Significant under expression of the DosR regulon in M. tuberculosis complex lineage 6 in sputum.

Authors:  Boatema Ofori-Anyinam; Gregory Dolganov; Tran Van; J Lucian Davis; Nicholas D Walter; Benjamin J Garcia; Marty Voskuil; Kristina Fissette; Maren Diels; Michèle Driesen; Conor J Meehan; Dorothy Yeboah-Manu; Mireia Coscolla; Sebastien Gagneux; Martin Antonio; Gary Schoolnik; Florian Gehre; Bouke C de Jong
Journal:  Tuberculosis (Edinb)       Date:  2017-03-04       Impact factor: 3.131

4.  High-resolution in situ transcriptomics of Pseudomonas aeruginosa unveils genotype independent patho-phenotypes in cystic fibrosis lungs.

Authors:  Elio Rossi; Marilena Falcone; Søren Molin; Helle Krogh Johansen
Journal:  Nat Commun       Date:  2018-08-27       Impact factor: 14.919

5.  Sputum microbiota profiles of treatment-naïve TB patients in Uganda before and during first-line therapy.

Authors:  David Patrick Kateete; Adrian Muwonge; Monica M Mbabazi; Faith Nakazzi; Fred A Katabazi; Edgar Kigozi; Willy Ssengooba; Lydia Nakiyingi; Sharon Namiiro; Alphonse Okwera; Moses L Joloba
Journal:  Sci Rep       Date:  2021-12-29       Impact factor: 4.379

6.  The In Vivo Transcriptomic Blueprint of Mycobacterium tuberculosis in the Lung.

Authors:  Mariateresa Coppola; Rachel P-J Lai; Robert J Wilkinson; Tom H M Ottenhoff
Journal:  Front Immunol       Date:  2021-12-22       Impact factor: 7.561

Review 7.  Host Transcriptomics as a Tool to Identify Diagnostic and Mechanistic Immune Signatures of Tuberculosis.

Authors:  Julie G Burel; Mariana Babor; Mikhail Pomaznoy; Cecilia S Lindestam Arlehamn; Nabeela Khan; Alessandro Sette; Bjoern Peters
Journal:  Front Immunol       Date:  2019-02-19       Impact factor: 7.561

Review 8.  Lipid droplets and the transcriptome of Mycobacterium tuberculosis from direct sputa: a literature review.

Authors:  Daniel Mekonnen; Awoke Derbie; Adane Mihret; Solomon Abebe Yimer; Tone Tønjum; Baye Gelaw; Endalkachew Nibret; Abaineh Munshae; Simon J Waddell; Abraham Aseffa
Journal:  Lipids Health Dis       Date:  2021-10-03       Impact factor: 4.315

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.